Cargando…
Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials
SIMPLE SUMMARY: For personalized treatment of metastatic spinal cord compression (MSCC), a patient’s remaining lifespan plays an important role, which can be estimated using prognostic factors. This study used data from 190 patients with poor or intermediate survival prognoses previously included in...
Autores principales: | Rades, Dirk, Cacicedo, Jon, Lomidze, Darejan, Al-Salool, Ahmed, Segedin, Barbara, Groselj, Blaz, Schild, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139528/ https://www.ncbi.nlm.nih.gov/pubmed/35626151 http://dx.doi.org/10.3390/cancers14102547 |
Ejemplares similares
-
Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
por: Rades, Dirk, et al.
Publicado: (2022) -
A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression
por: Rades, Dirk, et al.
Publicado: (2022) -
Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials
por: Rades, Dirk, et al.
Publicado: (2021) -
High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study
por: Rades, Dirk, et al.
Publicado: (2017) -
Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma
por: Rades, Dirk, et al.
Publicado: (2016)